Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBL-007 + Toripalimab in Advanced Malignancies
NCT05102006Phase 2Completed
- Sponsor
- Leads Biolabs
- Start
- Nov 2021
- Primary completion
- May 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of alcestobart in cancer, nasopharyngeal carcinoma (NPC), sponsored by Leads Biolabs. Started Nov 2021; status: completed.
02
Drugs
alcestobart
03
Conditions
cancernasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT05102006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05102006.